{
  "drugid": "RxNorm:283821",
  "drugname": "rasburicase",
  "guidelinename": "G6PD",
  "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/",
  "guidelinepharmgkbids": [
    "PA166119846"
  ],
  "citations": [
    null
  ],
  "recommendations": [
    {
      "implications": {
        "G6PD": "High risk of acute hemolytic anemia"
      },
      "drugrecommendation": "Avoid use",
      "classification": "Strong",
      "phenotypes": {
        "G6PD": "Deficient"
      },
      "activityscore": {},
      "allelestatus": {},
      "lookupkey": {
        "G6PD": "Deficient"
      },
      "comments": null,
      "population": "general",
      "genotypes": null,
      "source": "CPIC"
    },
    {
      "implications": {
        "G6PD": "High risk of acute on chronic hemolysis"
      },
      "drugrecommendation": "Avoid use",
      "classification": "Strong",
      "phenotypes": {
        "G6PD": "Deficient with CNSHA"
      },
      "activityscore": {},
      "allelestatus": {},
      "lookupkey": {
        "G6PD": "Deficient with CNSHA"
      },
      "comments": "Although there are not published data in individuals with the G6PD Deficient with CNSHA phenotype, there is a strong rationale to avoid these drugs based on evidence in G6PD Deficient individuals.",
      "population": "general",
      "genotypes": null,
      "source": "CPIC"
    },
    {
      "implications": {
        "G6PD": "Unknown risk of acute hemolytic anemia"
      },
      "drugrecommendation": "To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.",
      "classification": "Moderate",
      "phenotypes": {
        "G6PD": "Indeterminate"
      },
      "activityscore": {},
      "allelestatus": {},
      "lookupkey": {
        "G6PD": "Indeterminate"
      },
      "comments": null,
      "population": "general",
      "genotypes": null,
      "source": "CPIC"
    },
    {
      "implications": {
        "G6PD": "Low risk of acute hemolytic anemia"
      },
      "drugrecommendation": "No reason to avoid based on G6PD status",
      "classification": "Strong",
      "phenotypes": {
        "G6PD": "Normal"
      },
      "activityscore": {},
      "allelestatus": {},
      "lookupkey": {
        "G6PD": "Normal"
      },
      "comments": null,
      "population": "general",
      "genotypes": null,
      "source": "CPIC"
    },
    {
      "implications": {
        "G6PD": "Variable risk of acute hemolytic anemia"
      },
      "drugrecommendation": "To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.",
      "classification": "Moderate",
      "phenotypes": {
        "G6PD": "Variable"
      },
      "activityscore": {},
      "allelestatus": {},
      "lookupkey": {
        "G6PD": "Variable"
      },
      "comments": "Due to X-linked mosaicism, individuals with more than one X chromosome (e.g., females, individuals with Klinefelter syndrome) and heterozygous for one non-deficient (class IV) and one deficient (class Iâ€“III) allele may display a normal or a deficient phenotype; an enzyme activity test is needed to assign G6PD phenotype in such cases.",
      "population": "general",
      "genotypes": null,
      "source": "CPIC"
    }
  ],
  "genes": [
    "G6PD"
  ],
  "notesonusage": null,
  "cpicVersion": "v1.20.0",
  "source": "CPIC"
}